+ All Categories
Home > Documents > QST - pro

QST - pro

Date post: 13-Jan-2016
Category:
Upload: ova
View: 38 times
Download: 2 times
Share this document with a friend
Description:
QST - pro. David Yarnitsky MD Neurology, Rambam Med Ctr Technion Faculty of Medicine Haifa ISRAEL. Why would a clinical neurophysiologist want to conduct a QST test on his patient?. Quantify pathology Support diagnosis Follow-up natural history/treatment Predict future pain - PowerPoint PPT Presentation
32
Transcript
Page 1: QST - pro
Page 2: QST - pro

1. Quantify pathology

2. Support diagnosis

3. Follow-up natural history/treatment

4. Predict future pain

5. Predict response to therapy

Page 3: QST - pro

1.Quantifying sensory function

Static pain parameters Thresholds

Non painful modalities Hypo (-)

Painful modalities

Hypo (-)

Hyper (+)

Page 4: QST - pro

Quantifying sensory function

Static pain parameters

Non painful

neuropathyNeuropathic

pain

Non neuropathic

pain

Non painful modalities

Hypo (-)

Painful modalities

Hypo (-)

Hyper (+)

Page 5: QST - pro

Quantifying sensory function

ThresholdsNon painful

Neuropathy

Neuropathic

pain

Non neuropathic

pain

Non painful modalities

Hypo (-)

Painful modalities

Hypo (-)

Hyper (+)

Page 6: QST - pro

Pfau et al 2012

Page 7: QST - pro

23 C6-7 Radic, 8 NS neck-arm pain, 22 FM & 31 ctrls

Wide QST battery at painful and contralateral sites

2 .Supporting diagnosis

Page 8: QST - pro

Tampin et al, 2012

Page 9: QST - pro
Page 10: QST - pro

41 studies included PPT found most common QST 7 studies assessed session to session repeatability,

found quite good Estimated that 45 patients are needed to distinct OA

and ctrl groups for affected joint PPT

Page 11: QST - pro

Staד

Suokas et al, 2012

Standardized Mean Differences compared to controls

Page 12: QST - pro

Suokas et al, 2012

Pooled SMD (95% Conf.Int.)

Page 13: QST - pro

Sequential QST on face for 10 wks 40 patients undergoing oral surgery No post surgical sensory complaints

Page 14: QST - pro

Said-Yekta et al, 2012

Page 15: QST - pro

Said-Yekta et al, 2012

Page 16: QST - pro

Temporal summation (TS)

&

Conditioned pain modulation

(CPM, DNIC-like)

Page 17: QST - pro

time

• Psychophysical response to repetitive stimuli Psychophysical response to repetitive stimuli expressed by expressed by

increased pain rating along stimulationincreased pain rating along stimulation

• Equivalent to Equivalent to ‘‘wind-upwind-up’’ in spinal WDR neurons in spinal WDR neurons

Pain rating

Sti

mulu

s in

tensi

ty

Page 18: QST - pro

Sarlani & Greenspan,

2005

Page 19: QST - pro

Rt Rt

Lt

CPM = ∆ VAS (VAS Post – VAS Pre)

Conditioned - pre Conditioned - post

Conditioning

VA

ST

emp

Page 20: QST - pro

Efficient Less efficient

122 pre-operative patients

Page 21: QST - pro

Nachmias et al 2009

CPM in IBS and TMD

Page 22: QST - pro

Thoracotomy patients were:› Assessed for pain processing before

surgery, at pain-free time: Pain thresholds Pain60 CPM (DNIC), TS

› Undergone thoracotomy› Reported acute post-op pain (days 2 and

5) during: Cough Arm elevation

› Reported chronic post-op pain (6-12 month) During the week previous to clinic visit

Page 23: QST - pro
Page 24: QST - pro

TermOdds Ratio

(OR)

95% upper and lower OR

CPM (DNIC)0.500.28-0.79Baseline test-pain0.890.54-1.47

Acute pain1.861.29-2.98Pain threshold0.790.75-1.19

Surgery type [no rib #]0.620.28-1.30Gender [female]0.620.26-1.35

Age0.990.93-1.04

Page 25: QST - pro

If pain modulation is involved in the generation of pain, it could also be involved in its alleviation› then

If less efficient CPM leads to development of pain, improving CPM in pain patients could lead to alleviation of pain

Page 26: QST - pro

Pain assessed weekly, along: 1 baseline week 1 placebo week 1 week of 30 mg duloxetine 4 weeks of 60 mg duloxetine CPM, TS and other pain psychophysics at beginning and end.

Page 27: QST - pro

CPM predicts efficacy of duloxetine in painful diabetic neuropathy

Yarnitsky et al, 2012

Less efficient CPM

GAIN !!!

Efficient CPM

NO GAIN

!!!

Page 28: QST - pro

PredictorsB coefficients

Beta tP

Pre treatment depression

1.080.271.450.171

Initial spontaneous pain

0.290.241.030.321

Foot MDT5.530.160.740.475

Foot WDT-2.03-0.24-1.270.227

Placebo Effect-0.23-0.14-0.630.559

Pre treatment CPM

1.160.8224.200.001

Page 29: QST - pro
Page 30: QST - pro
Page 31: QST - pro

1. Quantify sensory changes – positive and negative (vs. EMG)

2. Discern neuropathic from non neuropathic pain states

3. Be used for follow-up on changes in sensory state, such as after surgery

4. Predict post operative pain

5. Predict efficacy of pain alleviating agents

Page 32: QST - pro

Iris Amor

Alon Sinai

Yelena Granovsky

Irit Weismann Fogel

David YarnitskyMichal Granot

Yonathan Crispel

Erica Dolnikov Liat Honigman Hadas AverbuchNachman

Ruth Moont

AndLab staff:Elliot SprecherDorit PudBeth MurrinsonRony NirRina Lev

Collaborators:Elon EisenbergRuth DefrinStefan LautenbacherEli EliavBob CoghillLars Arendt-NielsenOliver Wilder-SmithRami Burstein


Recommended